Helping Dogs with Mitral Valve Disease Live their Best Possible Life
0.5 CE Credit Hour / Veterinarians & Veterinary Technicians
Overview;
This session will focus on the most common cause of heart disease in dogs; mitral valve degeneration. We will discuss how to stage dogs using echocardiography and/or radiography, with emphasis on why staging is so important. Veterinarians should be comfortable managing dogs with all stages of heart disease regardless of whether referral to a cardiologist is possible or not. Staging is important because it informs the treatment approach as well as a monitoring plan. We will discuss the phenomenon of aldosterone breakthrough and how and why we address it with comprehensive RAAS suppression. The session will focus on practical approaches to ensuring that dogs with heart disease, and especially those with congestive heart failure, receive and benefit from all medications that have been shown to improve signs and longevity in this common condition.
Learning Objectives:
- Understand how and why to stage dogs with heart disease, even when referral to a cardiologist is not an option
- Apply the results of clinical studies that guide management of heart disease to clinical patients in a practical manner
- Develop a comprehensive medical plan that optimizes heart failure management for every patient and yet allows for individualized care, especially in advanced disease
Darcy Brittain Adin, DVM, DIP. ACVIM (Cardiology)
Dr. Darcy Adin is a Clinical Professor of Cardiology at the University of Florida, College of Veterinary Medicine. She received her DVM from Cornell University in 1996. She completed a rotating internship at VCA South Shore Animal Hospital in 1997 and a cardiology residency at the University of California, Davis in 1999, with ACVIM board certification in Cardiology in 2000. Dr. Adin has held positions in both academic and private specialty practice. Her clinical research focuses on the investigation of diuretic treatments and neurohormonal modulation of congestive heart failure.
Adam Christman, DVM, MBA
Adam Christman, DVM, MBA, is the chief veterinary officer for dvm360®—an MJH Life Sciences® company —who oversees content strategy and development and is the brand voice and personality for dvm360®’s multimedia channels, including dvm360 Live!™, The Vet Blast Podcast, continuing education webinars, and live media broadcasts. Christman also has been in private practice and shelter medicine for 18 years and is currently a member and treasurer of the New Jersey Veterinary Medical Association. He received his DVM degree from Iowa State University’s College of Veterinary Medicine in Ames, Iowa, and his MBA from Aspen University in Denver, Colorado.
Christman is a national thought leader, speaker, and author on practice management, social media, and rehabilitation, he has been featured in multiple publications and appeared on various multimedia shows throughout the United States, sharing his expertise and passion on all things veterinary medicine. As an avid social media influencer for animal health care, he has over 950,000 followers on TikTok and 53,000 followers on Instagram. He loves to engage with fellow pet parents and veterinary professionals across social media. Christman is an advocate of Pride VMC and Pawsibilities. He is also the proud dog dad to 5 dachshunds and believes no one should be deprived of the incredible human-animal bond.
This program has been approved for 0.5 hour of continuing education credit in jurisdictions that recognize RACE approval.
This
activity is funded by Ceva.
Important Safety Information:
Do not administer in conjunction with non-steroidal anti-inflammatory drugs (NSAIDs) in dogs with renal insufficiency. Do not use in dogs with hypoadrenocorticism (Addison's disease), hyperkalemia or hyponatremia.Do not use in dogs with known hypersensitivity to ACE inhibitors or spironolactone. The safety and effectiveness of concurrent therapy of Cardalis™ with pimobendan has not been evaluated. The safety of Cardalis™ has not been evaluated in pregnant, lactating, breeding, or growing dogs. Cardalis™ administration should begin after pulmonary edema is stabilized. Regular monitoring of renal function and serum potassium levels is recommended. Common side effects from a field study include anorexia, vomiting, lethargy, diarrhea and renal insufficiency.
Further prescribing info at: cevaconnect.com/cardiology
